1. Home
  2. MLTX vs APLE Comparison

MLTX vs APLE Comparison

Compare MLTX & APLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLTX
  • APLE
  • Stock Information
  • Founded
  • MLTX 2021
  • APLE 2007
  • Country
  • MLTX Switzerland
  • APLE United States
  • Employees
  • MLTX N/A
  • APLE N/A
  • Industry
  • MLTX Biotechnology: Pharmaceutical Preparations
  • APLE Real Estate Investment Trusts
  • Sector
  • MLTX Health Care
  • APLE Real Estate
  • Exchange
  • MLTX Nasdaq
  • APLE Nasdaq
  • Market Cap
  • MLTX 2.3B
  • APLE 2.7B
  • IPO Year
  • MLTX N/A
  • APLE 2015
  • Fundamental
  • Price
  • MLTX $38.60
  • APLE $11.75
  • Analyst Decision
  • MLTX Strong Buy
  • APLE Buy
  • Analyst Count
  • MLTX 8
  • APLE 4
  • Target Price
  • MLTX $80.50
  • APLE $17.25
  • AVG Volume (30 Days)
  • MLTX 434.1K
  • APLE 2.7M
  • Earning Date
  • MLTX 05-20-2025
  • APLE 05-01-2025
  • Dividend Yield
  • MLTX N/A
  • APLE 8.60%
  • EPS Growth
  • MLTX N/A
  • APLE N/A
  • EPS
  • MLTX N/A
  • APLE 0.79
  • Revenue
  • MLTX N/A
  • APLE $1,429,658,000.00
  • Revenue This Year
  • MLTX $103.42
  • APLE $2.20
  • Revenue Next Year
  • MLTX N/A
  • APLE $2.73
  • P/E Ratio
  • MLTX N/A
  • APLE $14.78
  • Revenue Growth
  • MLTX N/A
  • APLE 4.98
  • 52 Week Low
  • MLTX $31.42
  • APLE $10.44
  • 52 Week High
  • MLTX $58.26
  • APLE $16.50
  • Technical
  • Relative Strength Index (RSI)
  • MLTX 53.31
  • APLE 45.73
  • Support Level
  • MLTX $36.75
  • APLE $11.26
  • Resistance Level
  • MLTX $42.90
  • APLE $12.04
  • Average True Range (ATR)
  • MLTX 2.06
  • APLE 0.30
  • MACD
  • MLTX 0.03
  • APLE 0.06
  • Stochastic Oscillator
  • MLTX 58.04
  • APLE 41.88

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

About APLE Apple Hospitality REIT Inc.

Apple Hospitality REIT Inc is a real estate investment trust that invests in income-producing real estate, majorly in the lodging sector, in the United States. It chiefly invests in upscale service hotels. All of the company's hotels operate under the Marriott or Hilton brands. Apple Hospitality has wholly-owned taxable REIT subsidiaries, which lease all of the company's hotels from wholly-owned qualified REIT subsidiaries. These hotels are managed under separate agreements with various hotel management companies that are unaffiliated with Apple Hospitality. The company derives its income from hotel revenue, its sole segment.

Share on Social Networks: